JP-listed companies
Mochida Pharmaceutical Co.,Ltd.

Mochida Pharmaceutical Co.,Ltd.JP:4534

Market cap

¥117.6B

P/E ratio

39x

Income statement Balance sheet Cash flow

	Mar 31, 2013	Mar 31, 2014	Mar 31, 2015	Mar 31, 2016	Mar 31, 2017	Mar 31, 2018	Mar 31, 2019	Mar 31, 2020	Mar 31, 2021	Mar 31, 2022	Mar 31, 2023
Net sales	89,210	93,947	87,252	92,272	97,349	106,761	109,643	101,799	102,995	110,179	103,261
Cost of sales	32,797	34,364	33,913	37,273	41,043	53,182	55,477	49,882	48,203	50,626	48,146
Gross profit (loss)	56,412	59,582	53,339	54,998	56,306	53,578	54,166	51,917	54,791	59,553	55,114
Selling, general and administrative expenses	42,414	42,987	41,658	42,845	44,936	41,904	43,584	43,112	42,788	45,161	46,607
Operating profit (loss)	14,017	16,600	11,689	12,154	11,374	11,662	10,590	8,807	12,003	14,392	8,507
Interest income	24	19	19	22	7	3	3	3	3	2	2
Dividend income	161	129	143	186	199	220	243	250	254	284	338
Rental income from real estate	72	92	66	64	67	68	75	76	77	82	86
Gain on forgiveness of debts	-	-	-	-	-	-	-	-	-	6	165
Other	91	47	72	49	24	56	44	83	71	85	73
Non-operating income	348	289	302	360	340	392	408	413	405	455	665
Interest expenses	37	28	21	14	10	3	1	-	-	-	-
Commission expenses	101	21	26	99	36	36	37	41	41	43	45
Commission expenses	101	21	26	99	36	36	37	41	41	43	45
Other	16	7	34	9	4	6	4	8	3	5	6
Foreign exchange losses	23	35	25	2	15	-	27	15	102	-	36
Non-operating expenses	178	91	81	122	66	46	71	65	148	48	87
Other	16	7	34	9	4	6	4	8	3	5	6
Non-operating expenses	178	91	81	122	66	46	71	65	148	48	87
Ordinary profit (loss)	14,188	16,799	11,909	12,392	11,648	12,008	10,928	9,154	12,260	14,799	9,085
Gain on sale of non-current assets	-	-	-	-	-	194	-	-	5	-	-
Gain on sale of investment securities	32	29	-	156	-	-	254	1	-	526	-
Settlement income	-	-	-	-	-	-	1,557	3	27	-	8
Settlement income	-	-	-	-	-	-	1,557	3	27	-	8
Gain on sale of investment securities	32	29	-	156	-	-	254	1	-	526	-
Extraordinary income	32	30	54	156	-	194	1,850	195	35	564	13
Insurance claim income	-	-	-	-	-	-	-	-	-	38	4
Extraordinary income	32	30	54	156	-	194	1,850	195	35	564	13
Loss on sale and retirement of non-current assets	159	10	57	53	64	86	154	77	113	5	54
Impairment losses	-	-	765	397	-	-	981	-	-	107	-
Expenses for disposal of fixed assets	-	-	-	-	-	-	-	-	139	535	-
Loss on disaster	-	-	-	-	-	-	-	-	142	22	-
Settlement expenses	-	-	-	-	-	-	-	-	-	100	-
Expenses for disposal of fixed assets	-	-	-	-	-	-	-	-	139	535	-
Extraordinary losses	159	1,023	822	450	64	86	1,135	3,077	395	771	54
Settlement expenses	-	-	-	-	-	-	-	-	-	100	-
Extraordinary losses	159	1,023	822	450	64	86	1,135	3,077	395	771	54
Profit (loss) before income taxes	14,061	15,806	11,141	12,097	11,583	12,116	11,642	6,273	11,900	14,591	9,044
Income taxes - current	4,610	6,378	3,265	4,345	4,072	3,363	2,835	2,349	3,144	3,215	2,014
Income taxes - deferred	298	-465	331	-398	-1,014	-270	371	-674	168	807	380
Income taxes	4,909	5,913	3,597	3,946	3,057	3,092	3,207	1,675	3,312	4,022	2,395
Profit (loss)	-	-	7,544	8,150	8,526	9,023	8,435	4,598	8,587	10,569	6,649
Profit (loss) attributable to owners of parent	-	-	7,544	8,150	8,526	9,023	8,435	4,598	8,587	10,569	6,649